Nakai Hidekatsu 中井英勝

… Alternative Names

中井英勝ナカイヒデカツ

Less

Researcher Number	20441082
Other IDs
Affiliation (Current)	2025: 近畿大学, 医学部, 准教授
Affiliation (based on the past Project Information) *help	2025: 近畿大学, 医学部, 准教授 2023: 近畿大学, 医学部, 准教授 2022: 近畿大学, 医学部, 講師 2018: 近畿大学, 医学部, 講師 2016: 近畿大学, 医学部, 講師
Review Section/Research Field	Principal Investigator Basic Section 56040:Obstetrics and gynecology-related Except Principal Investigator Obstetrics and gynecology
Keywords	Principal Investigator 卵巣癌 / 化学療法の奏功規定因子 / 組織サブタイプ分類 / 高異型度漿液性癌 Except Principal Investigator 包括的遺伝子発現解析 / 腫瘍内ゲノム多様性 / 免疫療法 / 免疫 / ゲノム多様性 / 腫瘍ゲノム … More / 抗腫瘍免疫 / ゲノム診断 / 腫瘍免疫 / 卵巣癌 Less

卵巣高異型度漿液性癌におけるDNA修復機能のリアルタイムな評価方法の確立Principal Investigator
- Principal Investigator
  
  中井英勝
- Project Period (FY)
  2025 – 2029
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56040:Obstetrics and gynecology-related
- Research Institution
  Kindai University
卵巣高異型度漿液性癌に対する分子標的薬による個別化治療に向けた検討Principal Investigator
- Principal Investigator
  
  中井英勝
- Project Period (FY)
  2022 – 2024
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56040:Obstetrics and gynecology-related
- Research Institution
  Kindai University
Clinical utilization and investigation of ovarian cancer genome diversity associated with metastasis, resistance to treatment and immune escape
- Principal Investigator
  
  Mandai Masaki
- Project Period (FY)
  2016 – 2018
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Kyoto University
  Kindai University

All 2023 2022 2021 2016

All Journal Article Presentation

[Journal Article] Histopathological subtyping of high-grade serous ovarian cancer using whole slide imaging.2023
- Author(s)
  Miyagawa C, Nakai H, Otani T, Murakami R, Takamura S, Takaya H, Murakami K, Mandai M, Matsumura N.
- Journal Title
  
  J Gynecol Oncol.
  
  Volume: 34 Issue: 4
- DOI
  10.3802/jgo.2023.34.e47
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-22K09630, KAKENHI-PROJECT-23K27431, KAKENHI-PROJECT-23K27741
[Journal Article] Development of an Algorithm to Differentiate Uterine Sarcoma from Fibroids Using MRI and LDH Levels.2023
- Author(s)
  Suzuki A, Kido A, Matsuki M, Kotani Y, Murakami K, Yamanishi Y, Numoto I, Nakai H, Otani T, Konishi I, Mandai M, Matsumura N.
- Journal Title
  
  Diagnostics
  
  Volume: 13 Issue: 8 Pages: 1404-1404
- DOI
  10.3390/diagnostics13081404
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22K09630
[Journal Article] Veliparib with frontline chemotherapy and as maintenance in Japanese women with ovarian cancer: a subanalysis of efficacy, safety, and antiemetic use in the phase 3 VELIA trial.2023
- Author(s)
  Mizuno M, Ito K, Nakai H, Kato H, Kamiura S, Ushijima K, Nagao S, Takano H, Okadome M, Takekuma M, Tokunaga H, Nagase S, Aoki D, Coleman RL, Nishimura Y, Ratajczak CK, Hashiba H, Xiong H, Katsumata N, Enomoto T, Okamoto A.
- Journal Title
  
  Int J Clin Oncol.
  
  Volume: 28 Pages: 163-174
- Peer Reviewed / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-22K09630
[Journal Article] Progression after discontinuation of bevacizumab in the first-line treatment of ovarian cancer2023
- Author(s)
  Nakai Hidekatsu、Matsumura Noriomi
- Journal Title
  
  Annals of Translational Medicine
  
  Volume: 11 Issue: 5 Pages: 229-229
- DOI
  10.21037/atm-22-6389
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18H02947, KAKENHI-PROJECT-22K09630
[Journal Article] Selection of maintenance therapy during first-line treatment of advanced ovarian cancer based on pharmacologic characteristics.2023
- Author(s)
  Nakai H, Matsumura N.
- Journal Title
  
  Expert Opin Pharmacother.
  
  Volume: 24 Issue: 18 Pages: 2161-2173
- DOI
  10.1080/14656566.2023.2295393
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22K09630, KAKENHI-PROJECT-23K27741
[Journal Article] Comment on 'Population-adjusted indirect treatment comparison of maintenance PARP inhibitor with or without bevacizumab versus bevacizumab alone in women with newly diagnosed advanced ovarian cancer'.2023
- Author(s)
  Nakai H, Matsumura N.
- Journal Title
  
  Ther Adv Med Oncol.
  
  Volume: 15
- DOI
  10.1177/17588359231168509
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22K09630, KAKENHI-PROJECT-23K27741
[Journal Article] Time-Dependent Changes in Risk of Progression During Use of Bevacizumab for Ovarian Cancer2023
- Author(s)
  Takamatsu Shiro、Nakai Hidekatsu、Yamaguchi Ken、Hamanishi Junzo、Mandai Masaki、Matsumura Noriomi
- Journal Title
  
  JAMA Network Open
  
  Volume: 6 Issue: 8 Pages: 2326834-2326834
- DOI
  10.1001/jamanetworkopen.2023.26834
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-21K09541, KAKENHI-PROJECT-22K09630, KAKENHI-PROJECT-23K21473, KAKENHI-PROJECT-23K27741
[Journal Article] Treatment for Locally Resectable Stage IIIC1 Cervical Cancer: A Retrospective, Single-Institution Study.2023
- Author(s)
  Kashima Y, Murakami K, Miyagawa C, Takaya H, Kotani Y, Nakai H, Matsumura N.
- Journal Title
  
  Healthcare
  
  Volume: 11 Pages: 632-632
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22K09630
[Journal Article] Diagnostic Utility of Hysteroscopic Biopsy in Cases of Suspected Lobular Endocervical Glandular Hyperplasia and Comparison with Cervical Conization.2023
- Author(s)
  Shiro R, Kotani Y, Ohta M, Sato H, Kashima Y, Murakami K, Kawasaki K, Nakai H, Matsumura N.
- Journal Title
  
  Healthcare
  
  Volume: 11 Issue: 11 Pages: 1619-1619
- DOI
  10.3390/healthcare11111619
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22K09630
[Journal Article] Outcomes of Pregnancies and Deliveries of Patients Who Underwent Fertility-Preserving Surgery for Early-Stage Epithelial Ovarian Cancer.2022
- Author(s)
  Shin Nishio, Takayo Takeno, Takashi Fukuda, Aymi Shikama, Hidekastu Nakai, Hiroko Nakamura, Hideyuki Tokunaga, Kazuaki Takahashi, Emi Okuma, Masahiko Mori, Yasuhisa Terao, Kimio Ushijima, Nobuo Yaegashi.
- Journal Title
  
  . J Clin Med.
  
  Volume: 11 Issue: 18 Pages: 5346-5346
- DOI
  10.3390/jcm11185346
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22K09630
[Journal Article] Changes in HPV16/18 Prevalence among Unvaccinated Women with Cervical Intraepithelial Neoplasia in Japan: Assessment of Herd Effects following the HPV Vaccination Program.2022
- Author(s)
  Onuki M, Matsumoto K, et al. for The Mint Study Group.
- Journal Title
  
  Vaccines (Basel)
  
  Volume: 10 Issue: 2 Pages: 181-181
- DOI
  10.3390/vaccines10020188
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K11297, KAKENHI-PROJECT-17K11309, KAKENHI-PROJECT-19H03795, KAKENHI-PROJECT-19K09826, KAKENHI-PROJECT-20K09682, KAKENHI-PROJECT-20K09677, KAKENHI-PROJECT-22K09630
[Journal Article] The roles and limitations of bevacizumab in the treatment of ovarian cancer.2022
- Author(s)
  Hidekatsu Nakai, Noriomi Matsumura.
- Journal Title
  
  Int J Clin Oncol.
  
  Volume: 27 Issue: 7 Pages: 1120-1126
- DOI
  10.1007/s10147-022-02169-x
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22K09630, KAKENHI-PROJECT-18H02947, KAKENHI-PROJECT-20K21665
[Journal Article] Oncologic outcomes in elderly patients who underwent hysterectomy for endometrial cancer: a multi-institutional survey in Kinki District, Japan2022
- Author(s)
  Tanaka Tomohito、Matsumura Noriomi、et al.
- Journal Title
  
  International Journal of Clinical Oncology
  
  Volume: - Issue: 6 Pages: 1084-1092
- DOI
  10.1007/s10147-022-02152-6
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18H02947, KAKENHI-PROJECT-21K09523, KAKENHI-PROJECT-22K09630
[Journal Article] Individualization in the first-line treatment of advanced ovarian cancer based on the mechanism of action of molecularly targeted drugs.2022
- Author(s)
  Hidekatsu Nakai, Noriomi Matsuymura.
- Journal Title
  
  Int J Clin Oncol.
  
  Volume: 27 Issue: 6 Pages: 1001-1012
- DOI
  10.1007/s10147-022-02163-3
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-22K09630, KAKENHI-PROJECT-18H02947, KAKENHI-PROJECT-20K21665
[Journal Article] CXCL13-producing CD4+ T cells accumulate in the early phase of tertiary lymphoid structures in ovarian cancer2022
- Author(s)
  Ukita Masayo、Hamanishi Junzo、Yoshitomi Hiroyuki、Yamanoi Koji、Takamatsu Shiro、Ueda Akihiko、Suzuki Haruka、Hosoe Yuko、Furutake Yoko、Taki Mana、Abiko Kaoru、Yamaguchi Ken、Nakai Hidekatsu、Baba Tsukasa、Matsumura Noriomi、Yoshizawa Akihiko、Ueno Hideki、Mandai Masaki
- Journal Title
  
  JCI Insight
  
  Volume: 7 Issue: 12 Pages: 157215-157215
- DOI
  10.1172/jci.insight.157215
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K09541, KAKENHI-PROJECT-21K09548, KAKENHI-PROJECT-22K09630, KAKENHI-PROJECT-20K20610, KAKENHI-PROJECT-20K16431, KAKENHI-PROJECT-18H02947, KAKENHI-PROJECT-20K21665, KAKENHI-PROJECT-20K22810
[Journal Article] Regional differences in human papillomavirus type 52 prevalence among Japanese women with cervical intraepithelial neoplasia2022
- Author(s)
  Kukimoto Iwao、Onuki Mamiko、Yaegashi Nobuo、Matsumoto Koji、MINT Study Group
- Journal Title
  
  Japanese Journal of Clinical Oncology
  
  Volume: 52 Pages: 1428-1434
- DOI
  10.1093/jjco/hyac127
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20K09677, KAKENHI-PROJECT-20K09682, KAKENHI-PROJECT-22K09630, KAKENHI-PROJECT-20K09636
[Journal Article] Ovarian teratoid carcinosarcoma with a PIK3CA mutation: a case report and review of the literature.2022
- Author(s)
  Masato Aoki,　Hisamitsu Takaya, Tomoyuki Otani, Hidekatsu Nakai, Kosuke Murakami, Noriomi Matsumura.
- Journal Title
  
  Int Cancer Conf J.
  
  Volume: 11 Issue: 4 Pages: 231-237
- DOI
  10.1007/s13691-022-00571-w
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22K09630, KAKENHI-PROJECT-18H02947, KAKENHI-PROJECT-20K21665
[Journal Article] The efficacy of human papillomavirus vaccination in young Japanese girls: the interim results of the OCEAN study2021
- Author(s)
  Hiramatsu Kosuke、Matsumura Noriomi, et al.
- Journal Title
  
  Human Vaccines and Immunotherapeutics
  
  Volume: 18 Issue: 1 Pages: 1951098-1951098
- DOI
  10.1080/21645515.2021.1951098
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18H02947, KAKENHI-PROJECT-22K09630
[Presentation] Lynch症候群において組織型および遺伝子特性の異なる子宮・卵巣の重複癌を認めた一例2023
- Author(s)
  太田真見子, 宮川知保, 中井英勝, 松村謙臣
- Organizer
  第61回日本癌治療学会
- Data Source
  KAKENHI-PROJECT-22K09630
[Presentation] 治癒を目指した初回進行卵巣癌の維持療法2023
- Author(s)
  中井　英勝
- Organizer
  近畿産婦人科学会
- Data Source
  KAKENHI-PROJECT-22K09630
[Presentation] 卵巣癌に対するオラパリブ使用の人参養栄湯の効果についての前向き観察研究　KCOG-G1904 study2023
- Author(s)
  西江瑠璃, 藤原聡枝, 伊東史学, 谷口真紀子, 青木稚人, 中井英勝, 松村謙臣, 田崎和人, 西尾真, 吉岡恵美, 堀謙輔, 荒川敦志, 小池大我, 坊本佳優, 早崎容, 本橋卓, 伊藤公彦
- Organizer
  第65回日本婦人科腫瘍学会
- Data Source
  KAKENHI-PROJECT-22K09630
[Presentation] 当院の再発子宮内膜癌に対するPembrolizumab+Lenvatinib治療2023
- Author(s)
  佐藤華子, 加嶋洋子, 太田真見子, 宮川知保, 小谷泰史, 中井英勝, 松村謙臣
- Organizer
  近畿産婦人科学会
- Data Source
  KAKENHI-PROJECT-22K09630
[Presentation] 進行卵巣癌初回治療時のPARP阻害剤維持療法の投与状況を調べるための多機関共同研究2023
- Author(s)
  加嶋洋子, 松村謙臣, 中井英勝, 小谷泰史, 横井猛, 金村昌徳, 赤田忍, 坂元優太, 太田行信, 深山雅人
- Organizer
  日本産科婦人科学会
- Data Source
  KAKENHI-PROJECT-22K09630
[Presentation] 婦人科悪性腫瘍におけるMSI-high腫瘍についての多施設共同研究2023
- Author(s)
  加嶋洋子, 中井英勝, 松村謙臣, 吉岡恵美, 森泰輔, 金田倫子, 甲斐健太郎, 勝田隆博, 竹中基記, 荒川敦志, 伊藤公彦, 平嶋泰之, 寄木香織, 藤原聡枝, 望月亜矢子
- Organizer
  第65回日本婦人科腫瘍学会
- Data Source
  KAKENHI-PROJECT-22K09630
[Presentation] 卵巣高異型度漿液性癌の形態学的サブタイプ判定のためのトレーニングスライドの有用性2022
- Author(s)
  宮川知保, 中井英勝, 高矢寿光, 松村謙臣
- Organizer
  第64回日本婦人科腫瘍学会
- Data Source
  KAKENHI-PROJECT-22K09630
[Presentation] 多施設共同研究におけるプラチナ感受性再発卵巣癌に対するオラパリブの奏効期間についての後方視的検討2022
- Author(s)
  1 多施設共同研究におけるプラチナ感受性再発卵巣癌に対するオラパリ笹井奈穂, 中井英勝, 松村謙臣, 藤原聡枝, 磯野路善, 吉岡恵美, 西川隆太郎, 本橋卓, 荒川敦志
- Organizer
  第74回日本産科婦人科学会
- Data Source
  KAKENHI-PROJECT-22K09630
[Presentation] PARP阻害薬の変遷　卵巣高異型度漿液性がんにおけるHRD statusのintratumor heterogeneity2022
- Author(s)
  中井英勝, 高矢寿光, 松村謙臣
- Organizer
  第64回日本婦人科腫瘍学会
- Data Source
  KAKENHI-PROJECT-22K09630
[Presentation] 上皮性卵巣癌におけるコピー数多型と腫瘍クローン数についての検討2016
- Author(s)
  高矢寿光、坂井和子、浮田真沙世、中井英勝、西尾和人、万代昌紀
- Organizer
  日本産科婦人科遺伝診療学会
- Place of Presentation
  メルパルク京都(京都市)
- Year and Date
  2016-12-16
- Data Source
  KAKENHI-PROJECT-16H05477

1. 濱西潤三 (80378736)

# of Collaborated Projects: 2 results

# of Collaborated Products: 2 results
2. Mandai Masaki (80283597)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
3. 西尾和人 (10208134)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
4. 村上隆介 (40782363)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
5. 宮澤正顯 (60167757)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
6. 馬場長 (60508240)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
7. 鈴木彩子 (90378696)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
8. 松村謙臣 (20452336)

# of Collaborated Projects: 1 results

# of Collaborated Products: 19 results
9. 松本光司

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results
10. 滝真奈

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
11. 吉富啓之

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
12. 柊元巌

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
13. 小貫麻美子

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Nakai Hidekatsu 中井 英勝

中井 英勝 ナカイ ヒデカツ

Research Projects

Research Products

Co-Researchers

卵巣高異型度漿液性癌におけるDNA修復機能のリアルタイムな評価方法の確立Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

卵巣高異型度漿液性癌に対する分子標的薬による個別化治療に向けた検討Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Clinical utilization and investigation of ovarian cancer genome diversity associated with metastasis, resistance to treatment and immune escape

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Histopathological subtyping of high-grade serous ovarian cancer using whole slide imaging.2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Development of an Algorithm to Differentiate Uterine Sarcoma from Fibroids Using MRI and LDH Levels.2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Veliparib with frontline chemotherapy and as maintenance in Japanese women with ovarian cancer: a subanalysis of efficacy, safety, and antiemetic use in the phase 3 VELIA trial.2023

Author(s)

Journal Title

Data Source

[Journal Article] Progression after discontinuation of bevacizumab in the first-line treatment of ovarian cancer2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Selection of maintenance therapy during first-line treatment of advanced ovarian cancer based on pharmacologic characteristics.2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Comment on 'Population-adjusted indirect treatment comparison of maintenance PARP inhibitor with or without bevacizumab versus bevacizumab alone in women with newly diagnosed advanced ovarian cancer'.2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Time-Dependent Changes in Risk of Progression During Use of Bevacizumab for Ovarian Cancer2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Treatment for Locally Resectable Stage IIIC1 Cervical Cancer: A Retrospective, Single-Institution Study.2023

Author(s)

Journal Title

Data Source

[Journal Article] Diagnostic Utility of Hysteroscopic Biopsy in Cases of Suspected Lobular Endocervical Glandular Hyperplasia and Comparison with Cervical Conization.2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Outcomes of Pregnancies and Deliveries of Patients Who Underwent Fertility-Preserving Surgery for Early-Stage Epithelial Ovarian Cancer.2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Changes in HPV16/18 Prevalence among Unvaccinated Women with Cervical Intraepithelial Neoplasia in Japan: Assessment of Herd Effects following the HPV Vaccination Program.2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] The roles and limitations of bevacizumab in the treatment of ovarian cancer.2022

Author(s)

Journal Title

DOI

Nakai Hidekatsu 中井英勝

中井英勝ナカイヒデカツ

[Presentation] 卵巣癌に対するオラパリブ使用の人参養栄湯の効果についての前向き観察研究　KCOG-G1904 study2023

[Presentation] PARP阻害薬の変遷　卵巣高異型度漿液性がんにおけるHRD statusのintratumor heterogeneity2022